Gulraiz Chaudry, M.B.,Ch.B.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vascular Malformations | 15 | 2024 | 469 | 3.480 |
Why?
|
Lymphatic Abnormalities | 7 | 2020 | 134 | 3.180 |
Why?
|
Veins | 5 | 2024 | 767 | 1.720 |
Why?
|
Hemangioma | 5 | 2020 | 727 | 1.510 |
Why?
|
Radiography, Interventional | 7 | 2024 | 1127 | 1.180 |
Why?
|
Embolization, Therapeutic | 6 | 2019 | 1435 | 1.170 |
Why?
|
Osteolysis, Essential | 3 | 2019 | 30 | 1.060 |
Why?
|
Sclerotherapy | 5 | 2019 | 183 | 1.020 |
Why?
|
Hemangioma, Capillary | 2 | 2014 | 64 | 0.880 |
Why?
|
Klippel-Trenaunay-Weber Syndrome | 3 | 2019 | 69 | 0.860 |
Why?
|
Magnetic Resonance Angiography | 4 | 2014 | 1434 | 0.860 |
Why?
|
Muscle Neoplasms | 2 | 2014 | 130 | 0.830 |
Why?
|
Abscess | 2 | 2024 | 607 | 0.820 |
Why?
|
Hemangioendothelioma, Epithelioid | 2 | 2019 | 54 | 0.780 |
Why?
|
Drainage | 2 | 2024 | 1179 | 0.710 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2024 | 906 | 0.670 |
Why?
|
Musculoskeletal Abnormalities | 2 | 2018 | 101 | 0.650 |
Why?
|
Arteriovenous Malformations | 2 | 2020 | 396 | 0.640 |
Why?
|
Hepatic Artery | 2 | 2018 | 232 | 0.640 |
Why?
|
Portal Vein | 3 | 2018 | 432 | 0.640 |
Why?
|
Endovascular Procedures | 8 | 2024 | 2258 | 0.620 |
Why?
|
Hemangioendothelioma | 2 | 2016 | 112 | 0.610 |
Why?
|
Enbucrilate | 1 | 2018 | 30 | 0.600 |
Why?
|
Lymphatic Diseases | 3 | 2018 | 320 | 0.590 |
Why?
|
Soft Tissue Neoplasms | 2 | 2019 | 1166 | 0.590 |
Why?
|
Ultrasonography | 7 | 2020 | 5995 | 0.580 |
Why?
|
Capillaries | 1 | 2020 | 756 | 0.560 |
Why?
|
Arteriovenous Fistula | 2 | 2018 | 321 | 0.550 |
Why?
|
Renal Artery | 2 | 2020 | 353 | 0.550 |
Why?
|
Varicose Veins | 1 | 2018 | 157 | 0.540 |
Why?
|
Vena Cava Filters | 2 | 2011 | 270 | 0.540 |
Why?
|
Nevus | 1 | 2018 | 206 | 0.530 |
Why?
|
Lipoma | 1 | 2018 | 296 | 0.520 |
Why?
|
Phlebography | 4 | 2024 | 326 | 0.520 |
Why?
|
Parotid Neoplasms | 1 | 2017 | 158 | 0.510 |
Why?
|
Neck | 1 | 2020 | 736 | 0.510 |
Why?
|
Sarcoma, Kaposi | 2 | 2016 | 374 | 0.510 |
Why?
|
Ultrasonography, Interventional | 5 | 2020 | 1519 | 0.510 |
Why?
|
Child, Preschool | 31 | 2024 | 42623 | 0.490 |
Why?
|
Diagnostic Imaging | 4 | 2016 | 3543 | 0.470 |
Why?
|
Head | 1 | 2020 | 927 | 0.470 |
Why?
|
Growth Disorders | 1 | 2019 | 635 | 0.460 |
Why?
|
Paraganglioma, Extra-Adrenal | 1 | 2014 | 47 | 0.450 |
Why?
|
Glomus Tumor | 1 | 2014 | 62 | 0.440 |
Why?
|
Syndrome | 9 | 2024 | 3278 | 0.430 |
Why?
|
Fascia | 1 | 2014 | 141 | 0.430 |
Why?
|
Bleomycin | 1 | 2014 | 495 | 0.430 |
Why?
|
Device Removal | 3 | 2019 | 641 | 0.430 |
Why?
|
Pulmonary Embolism | 3 | 2019 | 2591 | 0.420 |
Why?
|
Infant | 24 | 2020 | 36497 | 0.400 |
Why?
|
Duodenal Diseases | 1 | 2013 | 101 | 0.400 |
Why?
|
Lymphangioleiomyomatosis | 1 | 2014 | 208 | 0.400 |
Why?
|
Child | 38 | 2024 | 80863 | 0.390 |
Why?
|
Aneurysm, False | 1 | 2014 | 263 | 0.390 |
Why?
|
Tissue Plasminogen Activator | 1 | 2017 | 1166 | 0.380 |
Why?
|
Liver Diseases | 2 | 2013 | 1307 | 0.380 |
Why?
|
Vascular Surgical Procedures | 5 | 2020 | 1509 | 0.380 |
Why?
|
Sclerosing Solutions | 1 | 2011 | 79 | 0.370 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2014 | 679 | 0.350 |
Why?
|
Heparin | 1 | 2017 | 1636 | 0.340 |
Why?
|
Bacteriocins | 1 | 2010 | 88 | 0.330 |
Why?
|
Biopsy, Needle | 2 | 2020 | 1629 | 0.330 |
Why?
|
Nephroma, Mesoblastic | 1 | 2009 | 24 | 0.330 |
Why?
|
Doxycycline | 1 | 2011 | 348 | 0.330 |
Why?
|
Arterial Occlusive Diseases | 3 | 2020 | 751 | 0.320 |
Why?
|
Enterococcus faecium | 1 | 2010 | 101 | 0.320 |
Why?
|
Thrombolytic Therapy | 1 | 2017 | 2058 | 0.300 |
Why?
|
Radiography, Thoracic | 3 | 2014 | 1320 | 0.300 |
Why?
|
Gastrointestinal Hemorrhage | 2 | 2013 | 1126 | 0.300 |
Why?
|
Fibrinolytic Agents | 1 | 2017 | 2082 | 0.290 |
Why?
|
Lymph Nodes | 3 | 2013 | 3472 | 0.280 |
Why?
|
Bone Neoplasms | 1 | 2019 | 2562 | 0.270 |
Why?
|
Foreign Bodies | 1 | 2011 | 403 | 0.270 |
Why?
|
Adolescent | 25 | 2024 | 89168 | 0.270 |
Why?
|
Tomography, X-Ray Computed | 5 | 2024 | 20762 | 0.260 |
Why?
|
Retrospective Studies | 25 | 2024 | 81834 | 0.260 |
Why?
|
Head and Neck Neoplasms | 1 | 2020 | 2915 | 0.260 |
Why?
|
Prosthesis Failure | 1 | 2011 | 1208 | 0.250 |
Why?
|
Treatment Outcome | 19 | 2024 | 65409 | 0.250 |
Why?
|
Liver Neoplasms | 2 | 2019 | 4362 | 0.250 |
Why?
|
Lymphography | 2 | 2019 | 189 | 0.250 |
Why?
|
Anticoagulants | 2 | 2018 | 4840 | 0.240 |
Why?
|
Vena Cava, Inferior | 1 | 2008 | 463 | 0.240 |
Why?
|
DNA, Bacterial | 1 | 2010 | 1474 | 0.240 |
Why?
|
Aorta, Abdominal | 3 | 2018 | 627 | 0.240 |
Why?
|
Male | 42 | 2024 | 364781 | 0.220 |
Why?
|
Humans | 61 | 2024 | 768451 | 0.220 |
Why?
|
Skin Neoplasms | 2 | 2014 | 5891 | 0.220 |
Why?
|
Pancreatic Diseases | 1 | 2006 | 353 | 0.220 |
Why?
|
Thrombosis | 1 | 2017 | 2956 | 0.210 |
Why?
|
Angiography | 3 | 2018 | 1598 | 0.210 |
Why?
|
Abnormalities, Multiple | 3 | 2019 | 1424 | 0.200 |
Why?
|
Bone and Bones | 1 | 2013 | 2589 | 0.200 |
Why?
|
Female | 38 | 2024 | 396943 | 0.190 |
Why?
|
Aortic Diseases | 2 | 2020 | 742 | 0.190 |
Why?
|
Radiology, Interventional | 2 | 2020 | 477 | 0.190 |
Why?
|
Boston | 6 | 2022 | 9361 | 0.190 |
Why?
|
Intestinal Diseases | 1 | 2006 | 505 | 0.190 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 2024 | 477 | 0.180 |
Why?
|
Magnetic Resonance Imaging | 9 | 2020 | 36840 | 0.180 |
Why?
|
Tissue Expansion Devices | 2 | 2020 | 160 | 0.180 |
Why?
|
Hypertension, Renovascular | 1 | 2020 | 115 | 0.180 |
Why?
|
Granuloma, Pyogenic | 1 | 2020 | 47 | 0.170 |
Why?
|
Renal Artery Obstruction | 1 | 2020 | 218 | 0.170 |
Why?
|
Pelvis | 1 | 2024 | 737 | 0.160 |
Why?
|
Rectum | 1 | 2024 | 902 | 0.160 |
Why?
|
Venous Thrombosis | 1 | 2008 | 1318 | 0.150 |
Why?
|
Diagnosis, Differential | 6 | 2020 | 13026 | 0.150 |
Why?
|
Peripheral Vascular Diseases | 2 | 2014 | 489 | 0.150 |
Why?
|
Infant, Newborn | 10 | 2020 | 26395 | 0.150 |
Why?
|
Foreign-Body Migration | 1 | 2019 | 220 | 0.140 |
Why?
|
Jejunostomy | 1 | 2017 | 61 | 0.140 |
Why?
|
Young Adult | 12 | 2019 | 60045 | 0.140 |
Why?
|
Radiography | 7 | 2014 | 6995 | 0.140 |
Why?
|
Septal Occluder Device | 1 | 2018 | 125 | 0.140 |
Why?
|
Appendicitis | 1 | 2024 | 687 | 0.140 |
Why?
|
Dilatation, Pathologic | 1 | 2018 | 528 | 0.140 |
Why?
|
Parotid Gland | 1 | 2017 | 178 | 0.130 |
Why?
|
Anti-Bacterial Agents | 2 | 2018 | 7471 | 0.130 |
Why?
|
Neurofibromin 1 | 1 | 2018 | 190 | 0.130 |
Why?
|
Cystic Fibrosis | 1 | 2006 | 1287 | 0.130 |
Why?
|
Predictive Value of Tests | 3 | 2024 | 15460 | 0.130 |
Why?
|
Upper Extremity | 2 | 2019 | 682 | 0.130 |
Why?
|
Hypertension, Pulmonary | 1 | 2007 | 1605 | 0.130 |
Why?
|
Catheterization, Central Venous | 1 | 2020 | 530 | 0.130 |
Why?
|
Muscular Diseases | 1 | 2020 | 555 | 0.130 |
Why?
|
Fluoroscopy | 2 | 2017 | 952 | 0.120 |
Why?
|
Prosthesis Design | 3 | 2018 | 2126 | 0.120 |
Why?
|
GTP Phosphohydrolases | 1 | 2018 | 525 | 0.120 |
Why?
|
Kidney Function Tests | 1 | 2017 | 681 | 0.120 |
Why?
|
Equipment Failure | 1 | 2017 | 585 | 0.120 |
Why?
|
Tachycardia, Ventricular | 1 | 2024 | 1309 | 0.120 |
Why?
|
Gastrostomy | 1 | 2017 | 325 | 0.120 |
Why?
|
Lower Extremity | 2 | 2020 | 1214 | 0.110 |
Why?
|
Neurofibromatoses | 1 | 2018 | 300 | 0.110 |
Why?
|
Blood Loss, Surgical | 1 | 2018 | 643 | 0.110 |
Why?
|
Angioplasty, Laser | 1 | 2013 | 17 | 0.110 |
Why?
|
Antibiotic Prophylaxis | 1 | 2018 | 640 | 0.110 |
Why?
|
Aorta | 1 | 2020 | 2046 | 0.100 |
Why?
|
Kidney Neoplasms | 1 | 2009 | 4298 | 0.100 |
Why?
|
Clinical Protocols | 1 | 2018 | 1444 | 0.100 |
Why?
|
Time Factors | 7 | 2020 | 40271 | 0.100 |
Why?
|
Vascular Diseases | 1 | 2020 | 1162 | 0.100 |
Why?
|
Aortic Coarctation | 1 | 2014 | 278 | 0.100 |
Why?
|
Muscle, Skeletal | 2 | 2020 | 4984 | 0.100 |
Why?
|
Thrombin | 1 | 2014 | 600 | 0.100 |
Why?
|
Knee Joint | 2 | 2011 | 1683 | 0.100 |
Why?
|
Skin Diseases | 1 | 2020 | 1099 | 0.100 |
Why?
|
Endothelial Cells | 2 | 2022 | 3586 | 0.090 |
Why?
|
Adult | 13 | 2020 | 223542 | 0.090 |
Why?
|
Chylothorax | 1 | 2011 | 83 | 0.090 |
Why?
|
Catheter Ablation | 1 | 2024 | 2775 | 0.090 |
Why?
|
Food Microbiology | 1 | 2010 | 74 | 0.080 |
Why?
|
Respiratory Function Tests | 1 | 2014 | 1697 | 0.080 |
Why?
|
Surgical Wound Infection | 1 | 2018 | 1544 | 0.080 |
Why?
|
Sex Distribution | 1 | 2014 | 2286 | 0.080 |
Why?
|
Sirolimus | 1 | 2016 | 1542 | 0.080 |
Why?
|
Risk Factors | 6 | 2020 | 74915 | 0.080 |
Why?
|
Mutation | 3 | 2024 | 30243 | 0.080 |
Why?
|
Surgical Instruments | 1 | 2011 | 386 | 0.080 |
Why?
|
Rare Diseases | 1 | 2014 | 630 | 0.080 |
Why?
|
Age Distribution | 1 | 2014 | 2881 | 0.070 |
Why?
|
Incidence | 2 | 2018 | 21552 | 0.070 |
Why?
|
Age Factors | 3 | 2020 | 18478 | 0.070 |
Why?
|
Lung, Hyperlucent | 1 | 2007 | 5 | 0.070 |
Why?
|
Catheterization | 1 | 2013 | 1431 | 0.070 |
Why?
|
Biopsy | 1 | 2019 | 6816 | 0.070 |
Why?
|
Hypertrophy, Right Ventricular | 1 | 2007 | 109 | 0.070 |
Why?
|
Dairy Products | 1 | 2010 | 490 | 0.070 |
Why?
|
Phenotype | 1 | 2024 | 16712 | 0.070 |
Why?
|
Bronchial Diseases | 1 | 2007 | 151 | 0.060 |
Why?
|
Polymerase Chain Reaction | 2 | 2018 | 6091 | 0.060 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2009 | 450 | 0.060 |
Why?
|
Joint Diseases | 1 | 2009 | 460 | 0.060 |
Why?
|
Hypertension | 2 | 2018 | 8611 | 0.060 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2010 | 1051 | 0.060 |
Why?
|
Sequence Alignment | 1 | 2010 | 2184 | 0.060 |
Why?
|
Aortic Valve Stenosis | 1 | 2018 | 2032 | 0.060 |
Why?
|
Surgery, Computer-Assisted | 2 | 2013 | 1005 | 0.060 |
Why?
|
Hyperthermia, Induced | 1 | 2009 | 417 | 0.060 |
Why?
|
Quality Improvement | 1 | 2020 | 3858 | 0.060 |
Why?
|
Gene Amplification | 1 | 2010 | 1091 | 0.060 |
Why?
|
Knee Injuries | 1 | 2009 | 495 | 0.060 |
Why?
|
Pain | 1 | 2020 | 5096 | 0.060 |
Why?
|
Cardiomegaly | 1 | 2007 | 591 | 0.060 |
Why?
|
Length of Stay | 1 | 2018 | 6521 | 0.060 |
Why?
|
Spine | 1 | 2011 | 1142 | 0.060 |
Why?
|
Follow-Up Studies | 4 | 2019 | 39430 | 0.060 |
Why?
|
Antihypertensive Agents | 1 | 2013 | 2028 | 0.050 |
Why?
|
Lung | 1 | 2022 | 10090 | 0.050 |
Why?
|
Microbial Sensitivity Tests | 1 | 2010 | 1965 | 0.050 |
Why?
|
Statistics as Topic | 1 | 2009 | 2362 | 0.050 |
Why?
|
Immunosuppressive Agents | 1 | 2016 | 4213 | 0.050 |
Why?
|
Spinal Cord | 1 | 2011 | 1814 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 1 | 2024 | 18048 | 0.050 |
Why?
|
Databases, Factual | 1 | 2017 | 8081 | 0.050 |
Why?
|
Membrane Proteins | 1 | 2018 | 7895 | 0.050 |
Why?
|
Mesenteric Arteries | 1 | 2020 | 178 | 0.040 |
Why?
|
Ischemia | 1 | 2009 | 1900 | 0.040 |
Why?
|
Vena Cava, Superior | 1 | 2020 | 197 | 0.040 |
Why?
|
Intestines | 1 | 2009 | 1912 | 0.040 |
Why?
|
Replantation | 1 | 2020 | 145 | 0.040 |
Why?
|
Combined Modality Therapy | 3 | 2019 | 8559 | 0.040 |
Why?
|
Tissue Expansion | 1 | 2020 | 163 | 0.040 |
Why?
|
Iliac Artery | 1 | 2020 | 344 | 0.040 |
Why?
|
Bone Marrow Transplantation | 1 | 2007 | 2702 | 0.040 |
Why?
|
Image Enhancement | 1 | 2009 | 2894 | 0.040 |
Why?
|
Suction | 1 | 2020 | 268 | 0.040 |
Why?
|
Neovascularization, Pathologic | 1 | 2009 | 2643 | 0.040 |
Why?
|
Base Sequence | 1 | 2010 | 12428 | 0.040 |
Why?
|
Neoplasm Staging | 1 | 2013 | 11249 | 0.040 |
Why?
|
Influenza, Human | 1 | 2009 | 1540 | 0.040 |
Why?
|
Catheters, Indwelling | 1 | 2020 | 436 | 0.040 |
Why?
|
Dissection | 1 | 2020 | 299 | 0.040 |
Why?
|
Amino Acid Sequence | 1 | 2010 | 13452 | 0.040 |
Why?
|
Pulmonary Artery | 1 | 2007 | 1949 | 0.040 |
Why?
|
Contrast Media | 2 | 2011 | 5336 | 0.040 |
Why?
|
Molecular Sequence Data | 1 | 2010 | 17647 | 0.030 |
Why?
|
Aortography | 1 | 2018 | 422 | 0.030 |
Why?
|
Transplantation, Autologous | 1 | 2020 | 2126 | 0.030 |
Why?
|
Blood Vessel Prosthesis | 1 | 2020 | 959 | 0.030 |
Why?
|
Anastomosis, Surgical | 1 | 2018 | 993 | 0.030 |
Why?
|
Graft vs Host Disease | 1 | 2007 | 3042 | 0.030 |
Why?
|
Echocardiography | 1 | 2007 | 5043 | 0.030 |
Why?
|
Graft Rejection | 1 | 2007 | 4505 | 0.030 |
Why?
|
Survival Rate | 2 | 2019 | 12875 | 0.030 |
Why?
|
Ethiodized Oil | 1 | 2011 | 26 | 0.020 |
Why?
|
Enteral Nutrition | 1 | 2017 | 804 | 0.020 |
Why?
|
Drug Resistance, Bacterial | 1 | 2018 | 1064 | 0.020 |
Why?
|
Disease Progression | 2 | 2019 | 13655 | 0.020 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2020 | 1460 | 0.020 |
Why?
|
Electrocardiography | 1 | 2024 | 6410 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 4861 | 0.020 |
Why?
|
Port-Wine Stain | 1 | 2010 | 33 | 0.020 |
Why?
|
Pedigree | 1 | 2018 | 4545 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2007 | 9066 | 0.020 |
Why?
|
Constriction, Pathologic | 1 | 2013 | 1103 | 0.020 |
Why?
|
Reoperation | 1 | 2020 | 4342 | 0.020 |
Why?
|
Facial Asymmetry | 1 | 2010 | 173 | 0.020 |
Why?
|
Algorithms | 1 | 2009 | 14158 | 0.020 |
Why?
|
Middle Aged | 2 | 2024 | 223418 | 0.020 |
Why?
|
Gastric Bypass | 1 | 2017 | 829 | 0.020 |
Why?
|
Consensus | 1 | 2018 | 3207 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2018 | 2742 | 0.020 |
Why?
|
Administration, Oral | 1 | 2016 | 4041 | 0.020 |
Why?
|
Patient Selection | 1 | 2020 | 4266 | 0.020 |
Why?
|
Recurrence | 1 | 2020 | 8510 | 0.020 |
Why?
|
Radiographic Image Enhancement | 1 | 2011 | 878 | 0.020 |
Why?
|
Aged | 1 | 2019 | 171520 | 0.020 |
Why?
|
Prognosis | 2 | 2019 | 30028 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2009 | 1585 | 0.020 |
Why?
|
Blood Pressure | 1 | 2020 | 8538 | 0.020 |
Why?
|
Liver | 1 | 2020 | 7575 | 0.010 |
Why?
|
Diagnostic Errors | 1 | 2011 | 1282 | 0.010 |
Why?
|
Anesthesia, General | 1 | 2011 | 1185 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2009 | 3438 | 0.010 |
Why?
|
Observer Variation | 1 | 2009 | 2622 | 0.010 |
Why?
|
Genetic Variation | 1 | 2018 | 6610 | 0.010 |
Why?
|
Cohort Studies | 2 | 2018 | 41797 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6537 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2014 | 3335 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2011 | 5308 | 0.010 |
Why?
|
Pilot Projects | 1 | 2011 | 8730 | 0.010 |
Why?
|
United States | 2 | 2018 | 73121 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2014 | 15965 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2009 | 14728 | 0.010 |
Why?
|
Quality of Life | 1 | 2016 | 13497 | 0.010 |
Why?
|
Risk Assessment | 1 | 2014 | 24311 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2009 | 20231 | 0.010 |
Why?
|
Prospective Studies | 1 | 2016 | 54914 | 0.010 |
Why?
|